A Vaccine Trial Recruiter Battles Mistrust - The Journal. - WSJ Podcasts

  • 📰 WSJ
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

🎧 Listen: In today's episode of The Journal podcast, an infectious-disease doctor who's working to recruit Black participants for Covid-19 vaccine trials explains why the diversity of those who partake may affect who trusts future vaccines

Kate Linebaugh is the co-host of The Journal. She has worked at The Wall Street Journal for 15 years, most recently as the deputy U.S. news coverage chief. Kate started at the Journal in Hong Kong, stopping in Detroit and coming to New York in 2011. As a reporter, she covered everything from post-9/11 Afghanistan to the 2004 Asian tsunami, from Toyota's sudden acceleration recall to General Electric.

Previously, he spent more than four years in the newsroom covering the wireless industry, and was responsible for a string of scoops including Verizon's $130 billion buyout of Vodafone's stake in their joint venture, Sprint and T-Mobile's never ending courtship and a hack of the 911 emergency system that spread virally on Twitter. He was also a regular author of A-heds, including one about millennials discovering TV antennas.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

That’s racist

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer says COVID-19 vaccine trial more than 50 percent enrolledEnrollment in the 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer Inc and German partner BioNTech is more than 50 percent complete, Dr. Nicholas Kitchin, a top Pfizer vaccine research and development scientist, said at the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meeting on Wednesday.
Source: Reuters - 🏆 2. / 97 Read more »

How L.A. doctors plan to include more people of color in COVID-19 vaccine trialDoctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they're aiming to recruit people of color and members of other high-risk groups. PrimeWednesdayService “People of color” All people have color. If they don’t, then they are likely translucent. Well hopefully they don't read the LAT's, which set out on a massive effort to discredit/smear anything to do with Trump's effort - Op Warp Speed - to develop and deliver vaccines ASAP. I suspect over 40 articles doing this so far. Turning millions into anti-vaxers forever.
Source: L.A. Times Health - 🏆 364. / 59 Read more »

Virginia Judge Rules Lee Statue Dispute Can Go to TrialVirginia Gov. Ralph Northam suffered a setback in his bid to take down a prominent statue of Confederate Gen. Robert E. Lee in Richmond, after a judge ruled that a lawsuit seeking to block the monument’s removal can proceed to trial is that the dude who likes to dress in blackface.. The same governor that dressed like the Klan in college. That’s good old Northam.
Source: WSJ - 🏆 98. / 63 Read more »

How L.A. doctors plan to include more people of color in COVID-19 vaccine trialDoctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they're aiming to recruit people of color and members of other high-risk groups. PrimeWednesdayService “People of color” All people have color. If they don’t, then they are likely translucent. Well hopefully they don't read the LAT's, which set out on a massive effort to discredit/smear anything to do with Trump's effort - Op Warp Speed - to develop and deliver vaccines ASAP. I suspect over 40 articles doing this so far. Turning millions into anti-vaxers forever.
Source: L.A. Times Health - 🏆 364. / 59 Read more »

Pfizer says COVID-19 vaccine trial more than 50 percent enrolledEnrollment in the 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer Inc and German partner BioNTech is more than 50 percent complete, Dr. Nicholas Kitchin, a top Pfizer vaccine research and development scientist, said at the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meeting on Wednesday.
Source: Reuters - 🏆 2. / 97 Read more »